Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra
Clinical trial NCT05308212 · COMPLETED
Trial details
- NCT number
- NCT05308212
- Sponsor
- St. Petersburg Research Institute of Vaccines and Sera
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-04
- Primary completion
- 2021-07-30
- Enrollment
- 633
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.